Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostaglandin synthesis (central) refers to the enzymatic process by which prostaglandins, a group of bioactive lipid mediators, are produced from arachidonic acid within cells, particularly within the central nervous system. This pathway is central to the regulation of inflammation, pain signaling, vascular tone, and other physiological processes. Key enzymes involved include phospholipase A2, cyclooxygenases (COX-1 and COX-2), and various terminal synthases that produce specific prostanoids like PGE2, PGD2, PGF2α, PGI2, and TXA2. Prostanoids exert their effects through specific G protein-coupled receptors (GPCRs).
Cyclooxygenase (COX) inhibition
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin Synthesis (Central).